136 related articles for article (PubMed ID: 27760216)
1. Nitric Oxide Donor Molsidomine Positively Modulates Myogenic Differentiation of Embryonic Endothelial Progenitors.
Tirone M; Conti V; Manenti F; Nicolosi PA; D'Orlando C; Azzoni E; Brunelli S
PLoS One; 2016; 11(10):e0164893. PubMed ID: 27760216
[TBL] [Abstract][Full Text] [Related]
2. Hemogenic endothelium generates mesoangioblasts that contribute to several mesodermal lineages in vivo.
Azzoni E; Conti V; Campana L; Dellavalle A; Adams RH; Cossu G; Brunelli S
Development; 2014 May; 141(9):1821-34. PubMed ID: 24757004
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 Signaling Negatively Modulates the Bipotential State of Hemogenic Endothelial Cells Derived from Embryonic Stem Cells by Attenuating the Endothelial Potential.
Ahmed T; Tsuji-Tamura K; Ogawa M
Stem Cells; 2016 Dec; 34(12):2814-2824. PubMed ID: 27340788
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP.
Buono R; Vantaggiato C; Pisa V; Azzoni E; Bassi MT; Brunelli S; Sciorati C; Clementi E
Stem Cells; 2012 Feb; 30(2):197-209. PubMed ID: 22084027
[TBL] [Abstract][Full Text] [Related]
5. The nitric oxide-donor molsidomine modulates the innate inflammatory response in a mouse model of muscular dystrophy.
Zordan P; Sciorati C; Campana L; Cottone L; Clementi E; Querini PR; Brunelli S
Eur J Pharmacol; 2013 Sep; 715(1-3):296-303. PubMed ID: 23707352
[TBL] [Abstract][Full Text] [Related]
6. Distinct hemogenic potential of endothelial cells and CD41+ cells in mouse embryos.
Hashimoto K; Fujimoto T; Shimoda Y; Huang X; Sakamoto H; Ogawa M
Dev Growth Differ; 2007 May; 49(4):287-300. PubMed ID: 17501906
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide disrupts VE-cadherin complex in murine microvascular endothelial cells.
González D; Herrera B; Beltrán A; Otero K; Quintero G; Rojas A
Biochem Biophys Res Commun; 2003 Apr; 304(1):113-8. PubMed ID: 12705893
[TBL] [Abstract][Full Text] [Related]
8. Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures.
Choi KD; Vodyanik MA; Togarrati PP; Suknuntha K; Kumar A; Samarjeet F; Probasco MD; Tian S; Stewart R; Thomson JA; Slukvin II
Cell Rep; 2012 Sep; 2(3):553-67. PubMed ID: 22981233
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide drives embryonic myogenesis in chicken through the upregulation of myogenic differentiation factors.
Cazzato D; Assi E; Moscheni C; Brunelli S; De Palma C; Cervia D; Perrotta C; Clementi E
Exp Cell Res; 2014 Jan; 320(2):269-80. PubMed ID: 24240125
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic Stem Cell-Independent Differentiation of Mast Cells From Mouse Intraembryonic VE-Cadherin+ Cells.
Tsuruda M; Morino-Koga S; Ogawa M
Stem Cells; 2022 Mar; 40(3):332-345. PubMed ID: 35294553
[TBL] [Abstract][Full Text] [Related]
11. Definitive human and mouse hematopoiesis originates from the embryonic endothelium: a new class of HSCs based on VE-cadherin expression.
Oberlin E; El Hafny B; Petit-Cocault L; Souyri M
Int J Dev Biol; 2010; 54(6-7):1165-73. PubMed ID: 20711993
[TBL] [Abstract][Full Text] [Related]
12. Development of a nitric oxide-releasing analogue of the muscle relaxant guaifenesin for skeletal muscle satellite cell myogenesis.
Wang G; Burczynski FJ; Hasinoff BB; Zhang K; Lu Q; Anderson JE
Mol Pharm; 2009; 6(3):895-904. PubMed ID: 19317416
[TBL] [Abstract][Full Text] [Related]
13. Skeletal muscle differentiation of embryonic mesoangioblasts requires pax3 activity.
Messina G; Sirabella D; Monteverde S; Galvez BG; Tonlorenzi R; Schnapp E; De Angelis L; Brunelli S; Relaix F; Buckingham M; Cossu G
Stem Cells; 2009 Jan; 27(1):157-64. PubMed ID: 18845762
[TBL] [Abstract][Full Text] [Related]
14. Functional Heterogeneity of Endothelial Cells Derived from Human Pluripotent Stem Cells.
D'Souza SS; Kumar A; Slukvin II
Stem Cells Dev; 2018 Apr; 27(8):524-533. PubMed ID: 29583085
[TBL] [Abstract][Full Text] [Related]
15. SOX7 regulates the expression of VE-cadherin in the haemogenic endothelium at the onset of haematopoietic development.
Costa G; Mazan A; Gandillet A; Pearson S; Lacaud G; Kouskoff V
Development; 2012 May; 139(9):1587-98. PubMed ID: 22492353
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy.
Sciorati C; Galvez BG; Brunelli S; Tagliafico E; Ferrari S; Cossu G; Clementi E
J Cell Sci; 2006 Dec; 119(Pt 24):5114-23. PubMed ID: 17158915
[TBL] [Abstract][Full Text] [Related]
17. Effects of a nitric oxide donor on behavior and interaction with nitrous oxide in the mouse light/dark exploration test.
Li S; Quock RM
Eur J Pharmacol; 2002 Jun; 447(1):75-8. PubMed ID: 12106805
[TBL] [Abstract][Full Text] [Related]
18. Local delivery of NO-donor molsidomine post-PTA improves haemodynamics, wall mechanics and histomorphometry in atherosclerotic porcine SFA.
Rolland PH; Bartoli JM; Piquet P; Mekkaoui C; Nott SH; Moulin G; Amabile P; Mesana T
Eur J Vasc Endovasc Surg; 2002 Mar; 23(3):226-33. PubMed ID: 11914009
[TBL] [Abstract][Full Text] [Related]
19. Developmental behavior of embryonic myogenic progenitors transplanted into adult muscle as revealed by desmin LacZ recombinant gene.
Auda-Boucher G; Rouaud T; Fontaine-Pérus J; Le Grand F; Gardahaut MF
J Histochem Cytochem; 2003 Oct; 51(10):1255-67. PubMed ID: 14500693
[TBL] [Abstract][Full Text] [Related]
20. Exogenous nitric oxide modulates the systemic inflammatory response and improves kidney function after risk-situation abdominal aortic surgery.
Lozano FS; López-Novoa JM; Rodriguez JM; Barros MB; García-Criado FJ; Nicolás JL; Parreño A; Revilla J; Gómez-Alonso A
J Vasc Surg; 2005 Jul; 42(1):129-39. PubMed ID: 16012462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
